• 1
    Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666675
  • 2
    Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690696
  • 3
    Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859866
  • 4
    Feifer A, Taylor J, Shouery M et al. B.C.A.N. Muscle-Invasive Bladder Cancer Quality of Care Consortium. Multi-institutional quality-of-care initiative for non-metastatic, muscle-invasive, transitional cell carcinoma of the bladder. J Clin Oncol 2011; 29 (Suppl. 7): 240 [abstract]
  • 5
    Stenzl A, Cowan NC, De Santis M et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59: 10091018
  • 6
    Shariat SF, Palapattu GS, Karakiewicz PI et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007; 51: 137151
  • 7
    Svatek RS, Shariat SF, Novara G et al. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 2011; 107: 898904
  • 8
    Bianco FJ, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004; 22: 290294
  • 9
    Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001; 166: 490493
  • 10
    Cheng L, Neumann RM, Weaver AL et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000; 113: 275279
  • 11
    Karakiewicz PI, Shariat SF, Palapattu GS et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 2006; 50: 12541262
  • 12
    Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI. Nomograms for bladder cancer. Eur Urol 2008; 54: 4153
  • 13
    Edge SB , Byrd DR , Compton CC , Fritz AG , Greene FL , Trotti A eds. American Joint Committee on Cancer (AJCC) Staging Manual, Seventh Edn. New York: Springer, 2010
  • 14
    Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARCC Press, 2004
  • 15
    Shariat SF, Svatek RS, Tilki D et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 14021412
  • 16
    Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565574
  • 17
    Sonpavde G, Shariat SF. Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed. Cancer 2012; 118: 811
  • 18
    Stimson CJ, Cookson MS, Barocas DA et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010; 183: 17321737
  • 19
    Favaretto RL, Shariat SF, Savage C et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 2012; 109: 7782
  • 20
    Quek ML, Stein JP, Nichols PW et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005; 174: 103106
  • 21
    Canter D, Guzzo T, Resnick M et al. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis. BJU Int 2008; 102: 952957
  • 22
    Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23: 65336539
  • 23
    Hong SK, Kwak C, Jeon HG, Lee E, Lee SE. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? Urology 2005; 65: 697702
  • 24
    Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 2003; 169: 955960
  • 25
    Resnick MJ, Bergey M, Magerfleisch L, Tomaszewski JE, Malkowicz SB, Guzzo TJ. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens. BJU Int 2011; 107: 4652
  • 26
    Vickers AJ. Prediction models: revolutionary in principle, but do they do more good than harm? J Clin Oncol 2011; 29: 29512952
  • 27
    Black PC, Brown GA, Dinney CP. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 2009; 27: 37